We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
IRadimed announces the successful closing of its $1.5 million first round of
private placement financing. "The funds will propel [IRadimed's] production
and marketing phase," said the company's founder and president, Roger Susi.
Vistakon, a division of Johnson & Johnson Vision Care, announced the availability
of Acuvue Advance Brand Contact Lenses for Astigmatism - the first silicone
hydrogel daily wear contact lens for individuals with astigmatism, a common
vision problem experienced by millions of children, teenagers and adults.
Kane Biotech, a biotechnology company engaged in the development of products
to prevent and disperse bacterial biofilms, announced that it has acquired the
worldwide exclusive license to all human and industrial applications of the
dispersin B enzyme from the University of Medicine and Dentistry of New Jersey.
Working in collaboration with Massachusetts General Hospital (MGH), Siemens
Medical Solutions has developed a prototype area-detector based, volume computed
tomography (CT) system.
Ciphergen Diagnostics, a division of Ciphergen Biosystems, announced that it
has executed a material transfer agreement with the NCI Clinical Proteomics
Reference Laboratory (CPRL) which allows CPRL to evaluate the new ProteinChip
System, Series 4000 and ProteinChip arrays and associated bioinformatics suites.
MedMira, a company specializing in rapid flow-through diagnostic technology,
announced that it has successfully completed the registration process with the
Ministry of Health in the United Arab Emirates (UAE).
Artes Medical, a privately held specialty pharmaceutical and medical device
company, announced it has begun qualification runs of its flagship product,
ArteFill, at its newly completed commercial cGMP manufacturing facility in San
Diego, Calif.
OpGen, a company specializing in single molecule
DNA analysis, announced that it has signed an exclusive distribution agreement
with M&S Instruments, a Japanese importer of pharmaceutical, biotechnology
and information technology tools and solutions.
Closure Medical's stockholders will vote June 2 on a proposal to approve the
merger agreement between Johnson & Johnson (J&J), Holden Merger Sub
-- a wholly owned subsidiary of J&J -- and Closure Medical.